Dermatology Stocks List Ranked for 2024 | NYSE,

Dermatology ETFs
Recent Dermatology News

Symbol	Grade	Name	% Change
INM	B	InMed Pharmaceuticals Inc.	9.93
ACRS	B	Aclaris Therapeutics, Inc.	9.09
FBRX	B	Forte Biosciences, Inc.	15.42
VYNE	B	VYNE Therapeutics Inc.	2.84
RCEL	B	Avita Medical Limited	-1.38
SSKN	C	Strata Skin Sciences, Inc.	0.32
BHC	C	Bausch Health Companies Inc.	-0.12
NBY	D	NovaBay Pharmaceuticals, Inc.	1.52
ELAN	D	Elanco Animal Health Incorporated	-0.30
DERM	D	Journey Medical Corporation	-0.57

View As Page of Charts

Related ETFs - A few ETFs which own one or more of the above listed Dermatology stocks.

Symbol	Grade	Name	Weight
XPH	B	SPDR S&P Pharmaceuticals ETF	3.35
PILL	C	Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF	2.18
FTXH	D	First Trust Nasdaq Pharmaceuticals ETF	1.83
BSMC	B	Brandes U.S. Small-Mid Cap Value ETF	1.49
MOO	D	Market Vectors Agribusiness ETF	1.34

View all Dermatology ETFs...

Compare ETFs

Compare FTXH to BSMC Compare FTXH to MOO Compare PILL to FTXH

Dermatology Stocks Recent News

Date	Stock	Title
Nov 22	ACRS	Aclaris Therapeutics And 2 Other US Penny Stocks To Watch
Nov 20	ACRS	Aclaris upgraded to overweight by Cantor on in-licensing deal
Nov 20	FBRX	Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
Nov 20	FBRX	Forte Biosciences announces oversubscribed $53 million private placement
Nov 20	FBRX	Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
Nov 20	ACRS	Aclaris Therapeutics upgraded to Buy from Hold at Jefferies
Nov 20	ACRS	Aclaris Therapeutics upgraded to Buy from Neutral at BTIG
Nov 19	ACRS	Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
Nov 19	ACRS	Aclaris stock soars for second day on licensing deal, analyst upgrades
Nov 19	ACRS	Aclaris Therapeutics secures global rights to Biosion’s antibodies
Nov 19	ACRS	ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
Nov 19	VYNE	VYNE Therapeutics initiated with a Buy at BTIG on I&I potential
Nov 18	ACRS	Aclaris stock rallies 53% amid licensing deal, Piper upgrade
Nov 18	BHC	US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
Nov 18	ACRS	Aclaris signs license deal for biologics assets
Nov 18	ACRS	Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
Nov 18	ACRS	Aclaris Therapeutics Announces $80 Million Private Placement
Nov 18	ACRS	Aclaris Therapeutics Announces Exclusive, Global License Agreement with Biosion, Inc., adding Potential Best-in-Class Biologics Assets to Pipeline
Nov 18	BHC	PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Nov 18	BHC	Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Dermatology: Dermatology (from ancient Greek δέρμα, derma which means skin and λογία, logia) is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist is a doctor that treats diseases, in the widest sense, and some cosmetic problems of the skin, scalp, hair, and nails.

More about Dermatology

Browse All Tags